Jennifer Barrett, Assistant Editor

Researchers have developed a novel peptide drug called FFW that could potentially reduce tumor growth and slow progression of liver cancer.

In 2017, the FDA reached new milestones with its highest number of generic drug approvals in a single month and a historic number of annual approvals, signaling promise for 2018.

The recent resurgence of mumps in the United States may be linked to waning vaccine protection, according to a recent analysis.

The Guardian Connect System can alert patients of potential high or low glucose events up to an hour in advance.

Emergency department (ED) visits in the United States for opioid overdoses are up, signaling that the epidemic is worsening, according to a recent CDC report.

In oral testimony before the US House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, FDA Commissioner Scott Gottlieb, MD, urged immediate steps that can be taken to enhance the product of existing licensed influenza vaccines.

Obesity has been considered a risk factor for severe acute respiratory illness, including more severe cases of the flu, but a recently-published study found that weight may not be associated with increased illness severity.

The American College of Physicians (ACP) recently issued new guidelines aimed at assisting clinicians in making decisions about targets when using pharmacologic therapy in adults with type 2 diabetes.

Personalized inpatient assessments prior to prescribing asthma therapy to pediatric patients can improve the accuracy and quality of care.

Despite signs that influenza activity is declining, overall activity remains elevated across most of the United States following this season’s peak in early February.

In addition to myocardial infarction and stroke, migraines may also be linked to an increased risk for venous thromboembolism and atrial fibrillation.

Twenty-two of 25 compounds in kratom bind to mu-opioid receptors.

The unemployment rate for pharmacists is only 2%, according to the US News & World Report.

Children with asthma who receive a combination of telemedicine support and school-based medication therapy may be less likely to need an asthma-related emergency room or hospital visit.

Officials with the FDA have announced labeling changes to prescription opioid cough and cold medications that contain codeine or hydrocodone.

Although substantial progress has been made in the advancement of HIV treatment and prevention, adherence remains a barrier for individuals taking medication on a frequent basis.

In recent weeks, increasing influenza activity in the United States reported from CDC surveillance data has made headlines, and health care providers are preparing for a challenging flu season.

Deaths related directly to cancer continue to decline in the United States, resulting in nearly 2.4 million fewer cancer-related deaths.

As part of their Drug Competition Action Plan, officials with the FDA have announced additional steps to encourage competition in the generic drug market.

US influenza activity has significantly increased over recent weeks, and health care providers should be vigilant about diagnosing and treating patients with the virus.

Significant novel drugs slated for review by the FDA in 2018.

With 2017 behind us, we’re looking ahead at the next year for what’s on the horizon in pharmacy.

A look at some of the top read articles on Pharmacy Times from 2017.

With the New Year on our heels, let’s look back on some of the most noteworthy FDA approvals of 2017.

Health care providers can administer egg-based influenza vaccines to people with egg allergy without taking precautions, according to a newly-updated influenza vaccine practice parameter from the Influenza Vaccine and Egg Allergy Practice Parameter Workgroup commissioned by Joint Task Force on Practice Parameters (JTFPP).

Officials with the FDA have approved voretigene neparvovec-rzyl (Luxturna, Spark Therapeutics), the first novel gene therapy for the treatment of an inherited form of vision loss in children and adults, according to an FDA press release.

As part of a larger effort to curb antimicrobial resistance, officials with the FDA have announced a new tool for providing critical information to health care providers about better managing antibiotics and antifungal drugs.

Several influenza activity indicators were higher than is typically seen for this time of year.

Updated diabetes treatment guidelines address the use of the medications with potential cardiovascular benefit.

Obesity will be a significant problem for more than half of US children if current trends continue, according to a study published in the New England Journal of Medicine.